ADORA3 and prostate carcinoma: We also analyzed gene expression in metastatic prostate cancer (GSE74685) and found a similar expression pattern, with ENTPD1, NT5E, and ADORA3 upregulation in bone metastases than in other metastases (Figure 3A), bottom.